Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) is a biopharmaceutical company developing innovative therapies that target various phases of cell cycle control for the treatment of cancer and other serious diseases.
Our strategy is to build a diversified portfolio of novel drug candidates to address areas of high unmet medical needs.